Industry Research Reports

Home > Reports > Food & Beverages > Global Bifidus Market Outlook, In‑Depth Analysis & Forecast to 2032

Global Bifidus Market Outlook, In‑Depth Analysis & Forecast to 2032

Industry: Food & Beverages

Published Date: 2026-03-26

Pages: 166 Pages

Report ld: 6352728

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global Bifidus market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

Bifidus is a genus of Gram-positive, non-motile, rod-shaped, sometimes forked, strictly anaerobic bacteria that are widely found in the digestive tract, vagina, and oral cavity of humans and animals. Bifidobacterium probiotics are an important classification of probiotics. They protect intestinal health by regulating the balance of intestinal flora and producing short-chain fatty acids to inhibit the growth of harmful bacteria and the formation of toxic metabolites. In addition, bifidobacteria also have multiple functions such as activating the phagocytic activity of macrophages, inhibiting the growth of tumor cells, and alleviating lactose intolerance.

From a downstream perspective, Food & Beverages accounted for % of 2025 revenue, surging to US$ million by 2032 (CAGR: % from 2026–2032).

Bifidus leading manufacturers (including Chr-Hansen, DuPont, Wecare Probiotics, Probi, Mitushi Bio Pharma, Scitop Bio-tech, Lallemand, Goerlich Pharma, Shandong Zhongke Jiayi Bioengineering, Danone, etc.), dominate supply; the top five capture approximately % of global revenue, with Chr-Hansen leading 2025 sales at US$ million.

Regional Outlook:

North America rose from US$ million in 2025 to a forecast US$ million by 2032 (CAGR %).

Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2025, % share rising to % by 2032), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).

Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2032 (CAGR %).

Report Includes:

This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global Bifidus market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customer distribution pattern.

Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.

Critical competitive intelligence profiles manufacturers (sales volume, revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.

MARKET SEGMENTATION

By Company

Chr-Hansen
DuPont
Wecare Probiotics
Probi
Mitushi Bio Pharma
Scitop Bio-tech
Lallemand
Goerlich Pharma
Shandong Zhongke Jiayi Bioengineering
Danone
Shanghai SPH Sinopharm

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Food Grade
Pharmaceutical Grade

Segment by Application

Food & Beverages
Medicines
Health Products
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Defines the Bifidus study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential

Chapter 2: Offers current market state, projects global revenue and sales to 2032, pinpointing high consumption regions and emerging market catalysts

Chapter 3: Dissects the manufacturer landscape: ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves

Chapter 4: Unlocks high margin product segments: compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks

Chapter 5: Targets downstream market opportunities: evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application

Chapter 6: North America: breaks down sales and revenue by Application and country, profiles key manufacturers and assesses growth drivers and barriers

Chapter 7: Europe: analyses regional sales, revenue and market by Application and manufacturers, flagging drivers and barriers

Chapter 8: Asia Pacific: quantifies sales and revenue by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas

Chapter 9: Central & South America: measures sales and revenue by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges

Chapter 10: Middle East and Africa: evaluates sales and revenue by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles

Chapter 11: Profiles manufacturers in depth: details product specs, sales, revenue, margins; top manufactures 2025 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments

Chapter 12: Supply chain: analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles

Chapter 13: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies

Chapter 14: Actionable conclusions and strategic recommendations.

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Allocate capital strategically to high growth regions (Chapters 6-10) and margin rich segments (Chapter 5).

Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.

Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).

Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).

Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Study Coverage

1.1 Introduction to Bifidus: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Bifidus Market Size by Type, 2021 vs 2025 vs 2032

1.2.2 Food Grade

1.2.3 Pharmaceutical Grade

1.3 Market Segmentation by Application

1.3.1 Global Bifidus Market Size by Application, 2021 vs 2025 vs 2032

1.3.2 Food & Beverages

1.3.3 Medicines

1.3.4 Health Products

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Bifidus Revenue Estimates and Forecasts (2021-2032)

2.2 Global Bifidus Revenue by Region

2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032

2.2.2 Historical and Forecasted Revenue by Region (2021-2032)

2.2.3 Global Revenue-Based Market Share by Region (2021-2032)

2.3 Global Bifidus Sales Estimates and Forecasts (2021-2032)

2.4 Global Bifidus Sales by Region

2.4.1 Sales Comparison: 2021 vs 2025 vs 2032

2.4.2 Historical and Forecasted Sales by Region (2021-2032)

2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends

2.4.4 Global Sales Market Share by Region (2021-2032)

3 Competitive Landscape

3.1 Global Bifidus Sales by Manufacturers

3.1.1 Global Sales Volume by Manufacturers (2021-2026)

3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2025)

3.2 Global Bifidus Manufacturer Revenue Rankings and Tiers

3.2.1 Global Revenue (Value) by Manufacturers (2021-2026)

3.2.2 Global Key Manufacturer Revenue Ranking (2024 vs. 2025)

3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

3.3 Manufacturer Profitability Profiles and Pricing Strategies

3.3.1 Gross Margin by Top Manufacturer (2021 vs 2025)

3.3.2 Manufacturer-Level Price Trends (2021-2026)

3.4 Key Manufacturers Manufacturing Base and Headquarters

3.5 Key Manufacturers Market Share by Product Type

3.5.1 Food Grade: Market Share by Key Manufacturers

3.5.2 Pharmaceutical Grade: Market Share by Key Manufacturers

3.6 Global Bifidus Market Concentration and Dynamics

3.6.1 Global Market Concentration

3.6.2 Entrant/Exit Impact Analysis

3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

4 Product Segmentation

4.1 Global Bifidus Sales Performance by Type

4.1.1 Global Bifidus Sales Volume by Type (2021-2032)

4.1.2 Global Bifidus Revenue by Type (2021-2032)

4.1.3 Global Average Selling Price (ASP) Trends by Type (2021-2032)

4.2 Product Technology Differentiation

4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk

4.3.1 High-Growth Niches and Adoption Drivers

4.3.2 Profitability Hotspots and Cost Drivers

4.3.3 Substitution Threats

5 Downstream Applications and Customers

5.1 Global Bifidus Sales by Application

5.1.1 Global Historical and Forecasted Sales by Application (2021-2032)

5.1.2 Global Sales Market Share by Application (2021-2032)

5.1.3 High-Growth Application Identification

5.1.4 Emerging Application Case Studies

5.2 Global Bifidus Revenue by Application

5.2.1 Global Historical and Forecasted Revenue by Application (2021-2032)

5.2.2 Revenue-Based Market Share by Application (2021-2032)

5.3 Global Pricing Dynamics by Application (2021-2032)

5.4 Downstream Customer Analysis

5.4.1 Top Customers by Region

5.4.2 Top Customers by Application

6 North America

6.1 North America Sales Volume and Revenue (2021-2032)

6.2 North America Key Manufacturers Sales Revenue in 2025

6.3 North America Bifidus Sales and Revenue by Application (2021-2032)

6.4 North America Growth Accelerators and Market Barriers

6.5 North America Bifidus Market Size by Country

6.5.1 North America Revenue by Country

6.5.2 North America Sales Trends by Country

6.5.3 US

6.5.4 Canada

6.5.5 Mexico

7 Europe

7.1 Europe Sales Volume and Revenue (2021-2032)

7.2 Europe Key Manufacturers Sales Revenue in 2025

7.3 Europe Bifidus Sales and Revenue by Application (2021-2032)

7.4 Europe Growth Accelerators and Market Barriers

7.5 Europe Bifidus Market Size by Country

7.5.1 Europe Revenue by Country

7.5.2 Europe Sales Trends by Country

7.5.3 Germany

7.5.4 France

7.5.5 U.K.

7.5.6 Italy

7.5.7 Russia

8 Asia-Pacific

8.1 Asia-Pacific Sales Volume and Revenue (2021-2032)

8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2025

8.3 Asia-Pacific Bifidus Sales and Revenue by Application (2021-2032)

8.4 Asia-Pacific Bifidus Market Size by Region

8.4.1 Asia-Pacific Revenue by Region

8.4.2 Asia-Pacific Sales Trends by Region

8.5 Asia-Pacific Growth Accelerators and Market Barriers

8.6 Southeast Asia

8.6.1 Southeast Asia Revenue by Country (2021 vs 2025 vs 2032)

8.6.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines

8.7 China

8.8 Japan

8.9 South Korea

8.10 China Taiwan

8.11 India

9 Central and South America

9.1 Central and South America Sales Volume and Revenue (2021-2032)

9.2 Central and South America Key Manufacturers Sales Revenue in 2025

9.3 Central and South America Bifidus Sales and Revenue by Application (2021-2032)

9.4 Central and South America Investment Opportunities and Key Challenges

9.5 Central and South America Bifidus Market Size by Country

9.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)

9.5.2 Brazil

9.5.3 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Sales Volume and Revenue (2021-2032)

10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2025

10.3 Middle East and Africa Bifidus Sales and Revenue by Application (2021-2032)

10.4 Middle East and Africa Investment Opportunities and Key Challenges

10.5 Middle East and Africa Bifidus Market Size by Country

10.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)

10.5.2 GCC Countries

10.5.3 Turkey

10.5.4 Egypt

10.5.5 South Africa

11 Corporate Profile

11.1 Chr-Hansen

11.1.1 Chr-Hansen Corporation Information

11.1.2 Chr-Hansen Business Overview

11.1.3 Chr-Hansen Bifidus Product Models, Descriptions and Specifications

11.1.4 Chr-Hansen Bifidus Sales, Price, Revenue and Gross Margin (2021-2026)

11.1.5 Chr-Hansen Bifidus Sales by Product in 2025

11.1.6 Chr-Hansen Bifidus Sales by Application in 2025

11.1.7 Chr-Hansen Bifidus Sales by Geographic Area in 2025

11.1.8 Chr-Hansen Bifidus SWOT Analysis

11.1.9 Chr-Hansen Recent Developments

11.2 DuPont

11.2.1 DuPont Corporation Information

11.2.2 DuPont Business Overview

11.2.3 DuPont Bifidus Product Models, Descriptions and Specifications

11.2.4 DuPont Bifidus Sales, Price, Revenue and Gross Margin (2021-2026)

11.2.5 DuPont Bifidus Sales by Product in 2025

11.2.6 DuPont Bifidus Sales by Application in 2025

11.2.7 DuPont Bifidus Sales by Geographic Area in 2025

11.2.8 DuPont Bifidus SWOT Analysis

11.2.9 DuPont Recent Developments

11.3 Wecare Probiotics

11.3.1 Wecare Probiotics Corporation Information

11.3.2 Wecare Probiotics Business Overview

11.3.3 Wecare Probiotics Bifidus Product Models, Descriptions and Specifications

11.3.4 Wecare Probiotics Bifidus Sales, Price, Revenue and Gross Margin (2021-2026)

11.3.5 Wecare Probiotics Bifidus Sales by Product in 2025

11.3.6 Wecare Probiotics Bifidus Sales by Application in 2025

11.3.7 Wecare Probiotics Bifidus Sales by Geographic Area in 2025

11.3.8 Wecare Probiotics Bifidus SWOT Analysis

11.3.9 Wecare Probiotics Recent Developments

11.4 Probi

11.4.1 Probi Corporation Information

11.4.2 Probi Business Overview

11.4.3 Probi Bifidus Product Models, Descriptions and Specifications

11.4.4 Probi Bifidus Sales, Price, Revenue and Gross Margin (2021-2026)

11.4.5 Probi Bifidus Sales by Product in 2025

11.4.6 Probi Bifidus Sales by Application in 2025

11.4.7 Probi Bifidus Sales by Geographic Area in 2025

11.4.8 Probi Bifidus SWOT Analysis

11.4.9 Probi Recent Developments

11.5 Mitushi Bio Pharma

11.5.1 Mitushi Bio Pharma Corporation Information

11.5.2 Mitushi Bio Pharma Business Overview

11.5.3 Mitushi Bio Pharma Bifidus Product Models, Descriptions and Specifications

11.5.4 Mitushi Bio Pharma Bifidus Sales, Price, Revenue and Gross Margin (2021-2026)

11.5.5 Mitushi Bio Pharma Bifidus Sales by Product in 2025

11.5.6 Mitushi Bio Pharma Bifidus Sales by Application in 2025

11.5.7 Mitushi Bio Pharma Bifidus Sales by Geographic Area in 2025

11.5.8 Mitushi Bio Pharma Bifidus SWOT Analysis

11.5.9 Mitushi Bio Pharma Recent Developments

11.6 Scitop Bio-tech

11.6.1 Scitop Bio-tech Corporation Information

11.6.2 Scitop Bio-tech Business Overview

11.6.3 Scitop Bio-tech Bifidus Product Models, Descriptions and Specifications

11.6.4 Scitop Bio-tech Bifidus Sales, Price, Revenue and Gross Margin (2021-2026)

11.6.5 Scitop Bio-tech Recent Developments

11.7 Lallemand

11.7.1 Lallemand Corporation Information

11.7.2 Lallemand Business Overview

11.7.3 Lallemand Bifidus Product Models, Descriptions and Specifications

11.7.4 Lallemand Bifidus Sales, Price, Revenue and Gross Margin (2021-2026)

11.7.5 Lallemand Recent Developments

11.8 Goerlich Pharma

11.8.1 Goerlich Pharma Corporation Information

11.8.2 Goerlich Pharma Business Overview

11.8.3 Goerlich Pharma Bifidus Product Models, Descriptions and Specifications

11.8.4 Goerlich Pharma Bifidus Sales, Price, Revenue and Gross Margin (2021-2026)

11.8.5 Goerlich Pharma Recent Developments

11.9 Shandong Zhongke Jiayi Bioengineering

11.9.1 Shandong Zhongke Jiayi Bioengineering Corporation Information

11.9.2 Shandong Zhongke Jiayi Bioengineering Business Overview

11.9.3 Shandong Zhongke Jiayi Bioengineering Bifidus Product Models, Descriptions and Specifications

11.9.4 Shandong Zhongke Jiayi Bioengineering Bifidus Sales, Price, Revenue and Gross Margin (2021-2026)

11.9.5 Shandong Zhongke Jiayi Bioengineering Recent Developments

11.10 Danone

11.10.1 Danone Corporation Information

11.10.2 Danone Business Overview

11.10.3 Danone Bifidus Product Models, Descriptions and Specifications

11.10.4 Danone Bifidus Sales, Price, Revenue and Gross Margin (2021-2026)

11.10.5 Danone Recent Developments

11.11 Shanghai SPH Sinopharm

11.11.1 Shanghai SPH Sinopharm Corporation Information

11.11.2 Shanghai SPH Sinopharm Business Overview

11.11.3 Shanghai SPH Sinopharm Bifidus Product Models, Descriptions and Specifications

11.11.4 Shanghai SPH Sinopharm Bifidus Sales, Price, Revenue and Gross Margin (2021-2026)

11.11.5 Shanghai SPH Sinopharm Recent Developments

12 Value Chain and Supply-Chain Analysis

12.1 Bifidus Industry Chain

12.2 Bifidus Upstream Materials Analysis

12.2.1 Raw Materials

12.2.2 Key Suppliers Market Share & Risk Assessment

12.3 Bifidus Integrated Production Analysis

12.3.1 Manufacturing Footprint Analysis

12.3.2 Regional Production Market Share (2021-2032)

12.3.3 Regulatory and Trade Policy Impact on Production

12.3.4 Production Technology Overview

12.3.5 Regional Cost Drivers

12.4 Bifidus Sales Channels and Distribution Networks

12.4.1 Sales Channels

12.4.2 Distributors

13 Bifidus Market Dynamics

13.1 Industry Trends and Evolution

13.2 Market Growth Drivers and Emerging Opportunities

13.3 Market Challenges, Risks, and Restraints

13.4 Impact of U.S. Tariffs

14 Key Findings in the Global Bifidus Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

15.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Author Details

TABLE OF FIGURES

List of Tables

Table 1. Global Bifidus Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)

Table 2. Global Bifidus Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)

Table 3. Global Bifidus Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 4. Global Bifidus Revenue by Region (US$ Million), 2021-2026

Table 5. Global Bifidus Revenue by Region (US$ Million), 2027-2032

Table 6. Global Bifidus Sales Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (K Units)

Table 7. Global Bifidus Sales by Region (K Units), 2021-2026

Table 8. Global Bifidus Sales by Region (K Units), 2027-2032

Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)

Table 10. Global Bifidus Sales by Manufacturers (K Units), 2021-2026

Table 11. Global Bifidus Sales Share by Manufacturers (2021-2026)

Table 12. Global Bifidus Revenue by Manufacturers (US$ Million), 2021-2026

Table 13. Global Bifidus Revenue-Based Market Share by Manufacturers (2021-2026)

Table 14. Global Key Manufacturers’Ranking Shift (2024 vs. 2025) (Based on Revenue)

Table 15. Global Manufacturer by Tier (Tier 1, Tier 2, and Tier 3), based on Bifidus Revenue, 2025

Table 16. Global Bifidus Average Gross Margin (%) by Manufacturer (2021 vs 2025)

Table 17. Global Bifidus Average Selling Price (ASP) by Manufacturers (US$/Unit), 2021-2026

Table 18. Key Manufacturers Bifidus Manufacturing Base and Headquarters

Table 19. Global Bifidus Market Concentration Ratio (CR5)

Table 20. Key Market Entrant/Exit (2021-2025) – Drivers & Impact Analysis

Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 22. Global Bifidus Sales Volume by Type (K Units), 2021-2026

Table 23. Global Bifidus Sales Volume by Type (K Units), 2027-2032

Table 24. Global Bifidus Revenue by Type (US$ Million), 2021-2026

Table 25. Global Bifidus Revenue by Type (US$ Million), 2027-2032

Table 26. Technical Specifications by Key Product Type

Table 27. Global Bifidus Sales by Application (K Units), 2021-2026

Table 28. Global Bifidus Sales by Application (K Units), 2027-2032

Table 29. Bifidus High-Growth Sectors Demand CAGR (2026-2032)

Table 30. Global Bifidus Revenue by Application (US$ Million), 2021-2026

Table 31. Global Bifidus Revenue by Application (US$ Million), 2027-2032

Table 32. Top Customers by Region

Table 33. Top Customers by Application

Table 34. North America Bifidus Growth Accelerators and Market Barriers

Table 35. North America Bifidus Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)

Table 36. North America Bifidus Sales (K Units) by Country (2021 vs 2025 vs 2032)

Table 37. Europe Bifidus Growth Accelerators and Market Barriers

Table 38. Europe Bifidus Revenue Grow Rate (CAGR) by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 39. Europe Bifidus Sales (K Units) by Country (2021 vs 2025 vs 2032)

Table 40. Asia-Pacific Bifidus Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 41. Asia-Pacific Bifidus Sales (K Units) by Country (2021 vs 2025 vs 2032)

Table 42. Asia-Pacific Bifidus Growth Accelerators and Market Barriers

Table 43. Southeast Asia Bifidus Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 44. Central and South America Bifidus Investment Opportunities and Key Challenges

Table 45. Central and South America Bifidus Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)

Table 46. Middle East and Africa Bifidus Investment Opportunities and Key Challenges

Table 47. Middle East and Africa Bifidus Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)

Table 48. Chr-Hansen Corporation Information

Table 49. Chr-Hansen Description and Major Businesses

Table 50. Chr-Hansen Product Models, Descriptions and Specifications

Table 51. Chr-Hansen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)

Table 52. Chr-Hansen Sales Value Proportion by Product in 2025

Table 53. Chr-Hansen Sales Value Proportion by Application in 2025

Table 54. Chr-Hansen Sales Value Proportion by Geographic Area in 2025

Table 55. Chr-Hansen Bifidus SWOT Analysis

Table 56. Chr-Hansen Recent Developments

Table 57. DuPont Corporation Information

Table 58. DuPont Description and Major Businesses

Table 59. DuPont Product Models, Descriptions and Specifications

Table 60. DuPont Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)

Table 61. DuPont Sales Value Proportion by Product in 2025

Table 62. DuPont Sales Value Proportion by Application in 2025

Table 63. DuPont Sales Value Proportion by Geographic Area in 2025

Table 64. DuPont Bifidus SWOT Analysis

Table 65. DuPont Recent Developments

Table 66. Wecare Probiotics Corporation Information

Table 67. Wecare Probiotics Description and Major Businesses

Table 68. Wecare Probiotics Product Models, Descriptions and Specifications

Table 69. Wecare Probiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)

Table 70. Wecare Probiotics Sales Value Proportion by Product in 2025

Table 71. Wecare Probiotics Sales Value Proportion by Application in 2025

Table 72. Wecare Probiotics Sales Value Proportion by Geographic Area in 2025

Table 73. Wecare Probiotics Bifidus SWOT Analysis

Table 74. Wecare Probiotics Recent Developments

Table 75. Probi Corporation Information

Table 76. Probi Description and Major Businesses

Table 77. Probi Product Models, Descriptions and Specifications

Table 78. Probi Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)

Table 79. Probi Sales Value Proportion by Product in 2025

Table 80. Probi Sales Value Proportion by Application in 2025

Table 81. Probi Sales Value Proportion by Geographic Area in 2025

Table 82. Probi Bifidus SWOT Analysis

Table 83. Probi Recent Developments

Table 84. Mitushi Bio Pharma Corporation Information

Table 85. Mitushi Bio Pharma Description and Major Businesses

Table 86. Mitushi Bio Pharma Product Models, Descriptions and Specifications

Table 87. Mitushi Bio Pharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)

Table 88. Mitushi Bio Pharma Sales Value Proportion by Product in 2025

Table 89. Mitushi Bio Pharma Sales Value Proportion by Application in 2025

Table 90. Mitushi Bio Pharma Sales Value Proportion by Geographic Area in 2025

Table 91. Mitushi Bio Pharma Bifidus SWOT Analysis

Table 92. Mitushi Bio Pharma Recent Developments

Table 93. Scitop Bio-tech Corporation Information

Table 94. Scitop Bio-tech Description and Major Businesses

Table 95. Scitop Bio-tech Product Models, Descriptions and Specifications

Table 96. Scitop Bio-tech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)

Table 97. Scitop Bio-tech Recent Developments

Table 98. Lallemand Corporation Information

Table 99. Lallemand Description and Major Businesses

Table 100. Lallemand Product Models, Descriptions and Specifications

Table 101. Lallemand Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)

Table 102. Lallemand Recent Developments

Table 103. Goerlich Pharma Corporation Information

Table 104. Goerlich Pharma Description and Major Businesses

Table 105. Goerlich Pharma Product Models, Descriptions and Specifications

Table 106. Goerlich Pharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)

Table 107. Goerlich Pharma Recent Developments

Table 108. Shandong Zhongke Jiayi Bioengineering Corporation Information

Table 109. Shandong Zhongke Jiayi Bioengineering Description and Major Businesses

Table 110. Shandong Zhongke Jiayi Bioengineering Product Models, Descriptions and Specifications

Table 111. Shandong Zhongke Jiayi Bioengineering Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)

Table 112. Shandong Zhongke Jiayi Bioengineering Recent Developments

Table 113. Danone Corporation Information

Table 114. Danone Description and Major Businesses

Table 115. Danone Product Models, Descriptions and Specifications

Table 116. Danone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)

Table 117. Danone Recent Developments

Table 118. Shanghai SPH Sinopharm Corporation Information

Table 119. Shanghai SPH Sinopharm Description and Major Businesses

Table 120. Shanghai SPH Sinopharm Product Models, Descriptions and Specifications

Table 121. Shanghai SPH Sinopharm Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)

Table 122. Shanghai SPH Sinopharm Recent Developments

Table 123. Key Raw Materials Distribution

Table 124. Raw Materials Key Suppliers

Table 125. Critical Raw Material Supplier Concentration (2025) & Risk Index

Table 126. Milestones in Production Technology Evolution

Table 127. Distributors List

Table 128. Market Trends and Market Evolution

Table 129. Market Drivers and Opportunities

Table 130. Market Challenges, Risks, and Restraints

Table 131. Research Programs/Design for This Report

Table 132. Key Data Information from Secondary Sources

Table 133. Key Data Information from Primary Sources

List of Figures

Figure 1. Bifidus Product Picture

Figure 2. Global Bifidus Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)

Figure 3. Food Grade Product Picture

Figure 4. Pharmaceutical Grade Product Picture

Figure 5. Global Bifidus Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)

Figure 6. Food & Beverages

Figure 7. Medicines

Figure 8. Health Products

Figure 9. Others

Figure 10. Bifidus Report Years Considered

Figure 11. Global Bifidus Revenue, (US$ Million), 2021 vs 2025 vs 2032

Figure 12. Global Bifidus Revenue (US$ Million), 2021-2032

Figure 13. Global Bifidus Revenue (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)

Figure 14. Global Bifidus Revenue-Based Market Share by Region (2021-2032)

Figure 15. Global Bifidus Sales (K Units), 2021-2032

Figure 16. Global Bifidus Sales (CAGR) by Region: 2021 vs 2025 vs 2032 (K Units)

Figure 17. Global Bifidus Sales Market Share by Region (2021-2032)

Figure 18. Top 5 and Top 10 Manufacturers Bifidus Sales Volume Market Share in 2025

Figure 19. Global Bifidus Revenue-Based Market Share Ranking (2025)

Figure 20. Tier Distribution by Revenue Contribution (2021 vs 2025)

Figure 21. Food Grade Revenue-Based Market Share by Manufacturer in 2025

Figure 22. Pharmaceutical Grade Revenue-Based Market Share by Manufacturer in 2025

Figure 23. Global Bifidus Sales Volume-Based Market Share by Type (2021-2032)

Figure 24. Global Bifidus Revenue-Based Market Share by Type (2021-2032)

Figure 25. Global Bifidus ASP by Type (US$/Unit), 2021-2032

Figure 26. Global Bifidus Revenue-Based Market Share (2021-2032)

Figure 27. Global Bifidus Sales Market Share by Application (2021-2032)

Figure 28. Global Bifidus Revenue-Based Market Share by Application (2021-2032)

Figure 29. Global Bifidus ASP by Application (US$/Unit), 2021-2032

Figure 30. North America Bifidus Sales YoY (K Units), 2021-2032

Figure 31. North America Bifidus Revenue YoY (US$ Million), 2021-2032

Figure 32. North America Top 5 Manufacturers Bifidus Sales Revenue (US$ Million) in 2025

Figure 33. North America Bifidus Sales Volume (K Units) by Application (2021-2032)

Figure 34. North America Bifidus Sales Revenue (US$ Million) by Application (2021-2032)

Figure 35. US Bifidus Revenue (US$ Million), 2021-2032

Figure 36. Canada Bifidus Revenue (US$ Million), 2021-2032

Figure 37. Mexico Bifidus Revenue (US$ Million), 2021-2032

Figure 38. Europe Bifidus Sales YoY (K Units), 2021-2032

Figure 39. Europe Bifidus Revenue YoY (US$ Million), 2021-2032

Figure 40. Europe Top 5 Manufacturers Bifidus Sales Revenue (US$ Million) in 2025

Figure 41. Europe Bifidus Sales Volume (K Units) by Application (2021-2032)

Figure 42. Europe Bifidus Sales Revenue (US$ Million) by Application (2021-2032)

Figure 43. Germany Bifidus Revenue (US$ Million), 2021-2032

Figure 44. France Bifidus Revenue (US$ Million), 2021-2032

Figure 45. U.K. Bifidus Revenue (US$ Million), 2021-2032

Figure 46. Italy Bifidus Revenue (US$ Million), 2021-2032

Figure 47. Russia Bifidus Revenue (US$ Million), 2021-2032

Figure 48. Asia-Pacific Bifidus Sales YoY (K Units), 2021-2032

Figure 49. Asia-Pacific Bifidus Revenue YoY (US$ Million), 2021-2032

Figure 50. Asia-Pacific Top 8 Manufacturers Bifidus Sales Revenue (US$ Million) in 2025

Figure 51. Asia-Pacific Bifidus Sales Volume (K Units) by Application (2021-2032)

Figure 52. Asia-Pacific Bifidus Sales Revenue (US$ Million) by Application (2021-2032)

Figure 53. Indonesia Bifidus Revenue (US$ Million), 2021-2032

Figure 54. Japan Bifidus Revenue (US$ Million), 2021-2032

Figure 55. South Korea Bifidus Revenue (US$ Million), 2021-2032

Figure 56. China Taiwan Bifidus Revenue (US$ Million), 2021-2032

Figure 57. India Bifidus Revenue (US$ Million), 2021-2032

Figure 58. Central and South America Bifidus Sales YoY (K Units), 2021-2032

Figure 59. Central and South America Bifidus Revenue YoY (US$ Million), 2021-2032

Figure 60. Central and South America Top 5 Manufacturers Bifidus Sales Revenue (US$ Million) in 2025

Figure 61. Central and South America Bifidus Sales Volume (K Units) by Application (2021-2032)

Figure 62. Central and South America Bifidus Sales Revenue (US$ Million) by Application (2021-2032)

Figure 63. Brazil Bifidus Revenue (US$ Million), 2021-2032

Figure 64. Argentina Bifidus Revenue (US$ Million), 2021-2032

Figure 65. Middle East, and Africa Bifidus Sales YoY (K Units), 2021-2032

Figure 66. Middle East and Africa Bifidus Revenue YoY (US$ Million), 2021-2032

Figure 67. Middle East and Africa Top 5 Manufacturers Bifidus Sales Revenue (US$ Million) in 2025

Figure 68. Middle East and Africa Bifidus Sales Volume (K Units) by Application (2021-2032)

Figure 69. Middle East and Africa Bifidus Sales Revenue (US$ Million) by Application (2021-2032)

Figure 70. GCC Countries Bifidus Revenue (US$ Million), 2021-2032

Figure 71. Turkey Bifidus Revenue (US$ Million), 2021-2032

Figure 72. Egypt Bifidus Revenue (US$ Million), 2021-2032

Figure 73. South Africa Bifidus Revenue (US$ Million), 2021-2032

Figure 74. Bifidus Industry Chain Mapping

Figure 75. Regional Bifidus Manufacturing Base Distribution (%)

Figure 76. Global Bifidus Production Market Share by Region (2021-2032)

Figure 77. Bifidus Production Process

Figure 78. Regional Bifidus Production Cost Structure

Figure 79. Channels of Distribution (Direct Vs Distribution)

Figure 80. Bottom-up and Top-down Approaches for This Report

Figure 81. Data Triangulation

Figure 82. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Bifidus market? zhanKai

The top companies in the global Bifidus market are Chr-Hansen、DuPont、Wecare Probiotics.

Related Reports

Global Bifidus Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Bifidus market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 99
USD 4250.00
(Single User License)
Bifidus- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Bifidus was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-19
Pages: 111
USD 3950.00
(Single User License)
Global Bifidus Market Research Report 2026
The global Bifidus market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-14
Pages: 123
USD 2900.00
(Single User License)
Global Bifidus Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Bifidus market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 152
USD 4900.00
(Single User License)
Global Bifidus Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Bifidus market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-13
Pages: 95
USD 4250.00
(Single User License)
Bifidus - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Bifidus was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-13
Pages: 119
USD 3950.00
(Single User License)
Global Bifidus Market Research Report 2025
The global market for Bifidus was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-13
Pages: 90
USD 2900.00
(Single User License)
Global Bifidus Market Research Report 2024
Bifidus is a genus of Gram-positive, non-motile, rod-shaped, sometimes forked, strictly anaerobic bacteria that are widely found in the digestive tract, vagina, and oral cavity of humans and animals. Bifidobacterium probiotics are an important classification of probiotics. They protect intestinal health by regulating the balance of intestinal flora and producing short-chain fatty acids to inhibit the growth of harmful bacteria and the formation of toxic metabolites. In addition, bifidobacteria also have multiple functions such as activating the phagocytic activity of macrophages, inhibiting the growth of tumor cells, and alleviating lactose intolerance.
Published Date: 2024-08-02
Pages: 89
USD 2900.00
(Single User License)
Global Bifidus Market Insights, Forecast to 2030
Bifidus is a genus of Gram-positive, non-motile, rod-shaped, sometimes forked, strictly anaerobic bacteria that are widely found in the digestive tract, vagina, and oral cavity of humans and animals. Bifidobacterium probiotics are an important classification of probiotics. They protect intestinal health by regulating the balance of intestinal flora and producing short-chain fatty acids to inhibit the growth of harmful bacteria and the formation of toxic metabolites. In addition, bifidobacteria also have multiple functions such as activating the phagocytic activity of macrophages, inhibiting the growth of tumor cells, and alleviating lactose intolerance.
Published Date: 2024-08-02
Pages: 157
USD 4900.00
(Single User License)
Global and United States Bifidus Market Report & Forecast 2024-2030
Bifidus is a genus of Gram-positive, non-motile, rod-shaped, sometimes forked, strictly anaerobic bacteria that are widely found in the digestive tract, vagina, and oral cavity of humans and animals. Bifidobacterium probiotics are an important classification of probiotics. They protect intestinal health by regulating the balance of intestinal flora and producing short-chain fatty acids to inhibit the growth of harmful bacteria and the formation of toxic metabolites. In addition, bifidobacteria also have multiple functions such as activating the phagocytic activity of macrophages, inhibiting the growth of tumor cells, and alleviating lactose intolerance.
Published Date: 2024-08-02
Pages: 131
USD 4350.00
(Single User License)

Global Bifidus Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Bifidus market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 99
USD 4250.00 (Single User License)
Bifidus- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Bifidus was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-19
Pages: 111
USD 3950.00 (Single User License)
Global Bifidus Market Research Report 2026
The global Bifidus market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-14
Pages: 123
USD 2900.00 (Single User License)
Global Bifidus Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Bifidus market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 152
USD 4900.00 (Single User License)
Global Bifidus Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Bifidus market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-13
Pages: 95
USD 4250.00 (Single User License)
Bifidus - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Bifidus was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-13
Pages: 119
USD 3950.00 (Single User License)
Global Bifidus Market Research Report 2025
The global market for Bifidus was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-13
Pages: 90
USD 2900.00 (Single User License)
Global Bifidus Market Research Report 2024
Bifidus is a genus of Gram-positive, non-motile, rod-shaped, sometimes forked, strictly anaerobic bacteria that are widely found in the digestive tract, vagina, and oral cavity of humans and animals. Bifidobacterium probiotics are an important classification of probiotics. They protect intestinal health by regulating the balance of intestinal flora and producing short-chain fatty acids to inhibit the growth of harmful bacteria and the formation of toxic metabolites. In addition, bifidobacteria also have multiple functions such as activating the phagocytic activity of macrophages, inhibiting the growth of tumor cells, and alleviating lactose intolerance.
Published: 2024-08-02
Pages: 89
USD 2900.00 (Single User License)
Global Bifidus Market Insights, Forecast to 2030
Bifidus is a genus of Gram-positive, non-motile, rod-shaped, sometimes forked, strictly anaerobic bacteria that are widely found in the digestive tract, vagina, and oral cavity of humans and animals. Bifidobacterium probiotics are an important classification of probiotics. They protect intestinal health by regulating the balance of intestinal flora and producing short-chain fatty acids to inhibit the growth of harmful bacteria and the formation of toxic metabolites. In addition, bifidobacteria also have multiple functions such as activating the phagocytic activity of macrophages, inhibiting the growth of tumor cells, and alleviating lactose intolerance.
Published: 2024-08-02
Pages: 157
USD 4900.00 (Single User License)
Global and United States Bifidus Market Report & Forecast 2024-2030
Bifidus is a genus of Gram-positive, non-motile, rod-shaped, sometimes forked, strictly anaerobic bacteria that are widely found in the digestive tract, vagina, and oral cavity of humans and animals. Bifidobacterium probiotics are an important classification of probiotics. They protect intestinal health by regulating the balance of intestinal flora and producing short-chain fatty acids to inhibit the growth of harmful bacteria and the formation of toxic metabolites. In addition, bifidobacteria also have multiple functions such as activating the phagocytic activity of macrophages, inhibiting the growth of tumor cells, and alleviating lactose intolerance.
Published: 2024-08-02
Pages: 131
USD 4350.00 (Single User License)